Akari Therapeutics Plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| IFP ADVISORS, INC | 04/13/2026 | 7.25 K | $877 | 100.00% | 0.02% |
| ARMISTICE CAPITAL, LLC | 05/15/2026 | 38.92 K | $200.45 K | 100.00% | 0.00% |
| CRESSET ASSET MANAGEMENT, LLC | 05/15/2026 | 20.56 K | $105.89 K | 100.00% | 0.00% |
| IFP ADVISORS, INC | 04/13/2026 | 181 | $932 | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 5 | $26 | 100.00% | 0.00% |
| MORGAN STANLEY | 05/15/2026 | 1 | $5 | 100.00% | 0.00% |
| TRUVESTMENTS CAPITAL LLC | 05/13/2026 | 1 | $5 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| STONEX GROUP INC. | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| PALO ALTO INVESTORS LP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| HIGHTOWER ADVISORS, LLC | 05/05/2026 | 0 | $0 | -100.00% | 0.00% |
| CERITY PARTNERS LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 05/12/2026 | 0 | $0 | -100.00% | 0.00% |
| WARBERG ASSET MANAGEMENT LLC | 05/07/2026 | 0 | $0 | -100.00% | 0.00% |
| ARMISTICE CAPITAL, LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 05/05/2026 | 0 | $0 | -100.00% | 0.00% |
| NEWEDGE ADVISORS, LLC | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| CWA ASSET MANAGEMENT GROUP, LLC | 04/20/2026 | 0 | $0 | -100.00% | 0.00% |
| INDEPENDENT ADVISOR ALLIANCE | 05/12/2026 | 0 | $0 | -100.00% | 0.00% |
| TRUVESTMENTS CAPITAL LLC | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
| CRESSET ASSET MANAGEMENT, LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| CORNERSTONE PLANNING GROUP LLC | 05/06/2026 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 0 | $0 | -100.00% | 0.00% |
| ACCENT CAPITAL MANAGEMENT, LLC | 05/11/2026 | 0 | $0 | -100.00% | 0.00% |
| 04/21/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Akari Therapeutics Plc institutional Ownership - FAQ's
During the previous two years, 23 institutional investors and hedge funds held shares of Akari Therapeutics Plc. The most heavily invested institutionals were:
ARMISTICE CAPITAL, LLC: 38,922
Cresset Asset Management, LLC: 20,561
IFP Advisors, Inc: 7,431
SBI Securities Co., Ltd.: 5
MORGAN STANLEY: 1
Truvestments Capital LLC: 1
0.20% of Akari Therapeutics Plc stock is owned by institutional investors.
Institutional investors have bought a total of 238.77 K shares in the last 24 months. This purchase volume represents approximately $59.69 K in transactions.